C39H71NO13
Neat
762.00
-20°C
Room Temperature
128940-83-0; Clarithromycin EP Impurity F; Clarithromycin Impurity F; (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-6-[(2S, 3R, 4S, 6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12-hydroxy-4-[(2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyloxan-2-yl]oxy-7, 13-dimethoxy-3, 5, 7, 9, 11, 13-hexamethyl-oxacyclotetradecane-2, 10-dione; 12-O-Methyl Clarithromycin (>90%); 12-O-Methyl Clarithromycin; 6, 12-Di-O-methylerythromycin; 12-O-Methyl Clarithromycin (~90%); 6, 12-Di-O-methylerythromycin A; 6, 12-Di-O-methylerythromycin; Oxacyclotetradecane, erythromycin deriv.; 12-O-Methylclarithromycin; 6, 12-Di-O-methylerythromycin A; Clarithromycin Imp. F (EP); 12-O-Methylclarithromycin; 5MB8Z3G5B8; DTXSID90561938; PUBCHEM_14589671; Erythromycin, 6, 12-di-O-methyl-; FC166150; H60542; (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-6-(((2S, 3R, 4S, 6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12-hydroxy-4-(((2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7, 13-dimethoxy-3, 5, 7, 9, 11, 13-hexamethyloxacyclotetradecane-2, 10-dione; (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-6-[(2S, 3R, 4S, 6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12-hydroxy-4-[(2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyl-tetrahydropyran-2-yl]oxy-7, 13-dimethoxy-3, 5, 7, 9, 11, 13-hexamethyl-oxacyclotetradecane-2 and 10-dione
(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-6-[(2S, 3R, 4S, 6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12-hydroxy-4-[(2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyloxan-2-yl]oxy-7, 13-dimethoxy-3, 5, 7, 9, 11, 13-hexamethyl-oxacyclotetradecane-2 and 10-dione
InChI=1S/C39H71NO13/c1-16-27-39(10,48-15)32(43)22(4)29(41)20(2)18-38(9,47-14)34(53-36-30(42)26(40(11)12)17-21(3)49-36)23(5)31(24(6)35(45)51-27)52-28-19-37(8,46-13)33(44)25(7)50-28/h20-28,30-34,36,42-44H,16-19H2,1-15H3/t20-,21-,22+,23+,24-,25+,26+,27-,28+,30-,31+,32-,33+,34-,36+,37-,38-,39-/m1/s1